Mostrando 9 resultados de: 9
Filtros aplicados
Área de conocimiento
Ginecología(4)
Obstetricia(3)
Psicología(1)
Salud mental(1)
Trastorno depresivo mayor(1)
Origen
scopus(9)
Current management of pelvic organ prolapse in aging women: EMAS clinical guide
ArticleAbstract: Management of pelvic organ prolapse (POP) is a common and challenging task. Nowadays older women arePalabras claves:aging, management, Pelvic organ prolapse, Urinary incontinenceAutores:Cano A., Giannini A., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Russo E., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.Fuentes:scopusEMAS position statement: Pbkp_redictors of premature and early natural menopause
ArticleAbstract: Introduction: While the associations of genetic, reproductive and environmental factors with the timPalabras claves:Aetiology, Early menopause, Premature ovarian insufficiency, RISK FACTORSAutores:Cano A., Chung H.F., Goulis D.G., Lambrinoudaki I., Lopes P., Mishra G.D., Mueck A., Peter A. Chedraui, Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Tuomikoski P.Fuentes:scopusOptimal management of osteoporotic women in the gynecological consultation
ReviewAbstract: Osteoporosis is a skeletal metabolic disorder characterized by compromised bone strength pbkp_redispPalabras claves:Bisphosphonates, bone mineral density, Bone turnover markers, calcium, Densitometry, Osteopenia, Postmenopausal women, synergy, vitamin DAutores:Calaf J., Cano A., Faustino R. Pérez-López, Ferrer Barriendos J., Vázquez F.Fuentes:scopusManagement of depressive symptoms in peri- and postmenopausal women: EMAS position statement
ArticleAbstract: Introduction: Globally, the total number of people with depression exceeds 300 million, and the inciPalabras claves:Depression, Early menopause, EMAS, menopausal hormone therapy, Menopausal transition, Model of care, PERIMENOPAUSEAutores:Bitzer J., Cano A., Ceausu I., Durmusoglu F., Erkkola R., Goulis D.G., Karageorgiou V., Kiesel L., Lambrinoudaki I., Lindén Hirschberg A., Lopes P., Peter A. Chedraui, Pines A., Rees M., Spyropoulou A., Stute P., van Trotsenburg M., Zervas I.Fuentes:scopusManagement of urinary incontinence in postmenopausal women: An EMAS clinical guide
ArticleAbstract: Introduction: The prevalence of urinary incontinence and of other lower urinary tract symptoms increPalabras claves:aging, estrogens, MENOPAUSE, Midurethral slings, Urinary incontinenceAutores:Bitzer J., Cano A., Caretto M., Ceausu I., Durmusoglu F., Erkkola R., Giannini A., Goulis D.G., Hirschberg A.L., Kiesel L., Lambrinoudaki I., Lopes P., Peter A. Chedraui, Pines A., Rees M., Russo E., Simoncini T., van Trotsenburg M.Fuentes:scopusMenopause and diabetes: EMAS clinical guide
ArticleAbstract: Introduction: Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independentlyPalabras claves:menopausal hormone therapy, MENOPAUSE, Type 2 Diabetes mellitusAutores:Anagnostis P., Cano A., Goulis D.G., Jaremek J.D., Lambrinoudaki I., Lopes P., Meczekalski B., Mishra G.D., Mueck A., Paschou S.A., Peter A. Chedraui, Rees M., Rogowicz-Frontczak A., Senturk L.M., Simoncini T., Slopien R., Stevenson J.C., Stute P., Tuomikoski P., Wender-Ozegowska E., Zozulinska-Ziolkiewicz D.Fuentes:scopusMenopause symptom management in women with dyslipidemias: An EMAS clinical guide
ReviewAbstract: Introduction: Dyslipidemias are common and increase the risk of cardiovascular disease. The menopausPalabras claves:Cardiovascular disease, Dyslipidemia(s), menopausal hormone therapy, MENOPAUSE, Premature menopause, statinsAutores:Anagnostis P., Bitzer J., Cano A., Ceausu I., Durmusoglu F., Erkkola R., Goulis D.G., Hirschberg A.L., Kiesel L., Lambrinoudaki I., Lopes P., Peter A. Chedraui, Pines A., Rees M., van Trotsenburg M.Fuentes:scopusThe early response of the postmenopausal endometrium to tamoxifen: Expression of estrogen receptors, progesterone receptors, and Ki-67 antigen
ArticleAbstract: Objective: To enlighten the early response of endometrium to tamoxifen by assessing the expression oPalabras claves:Early response, Endometrium, Estrogen receptors, Ki-67, progesterone receptors, TamoxifenAutores:Cano A., J. E. Blümel, Tarín J.J., Tregón M.L.Fuentes:scopusTopical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide
ArticleAbstract: Introduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It afPalabras claves:Autores:Bitzer J., Cano A., Ceausu I., Durmusoglu F., Erkkola R., Goulis D.G., Hirschberg A.L., Kiesel L., Lambrinoudaki I., Lopes P., Peter A. Chedraui, Pines A., Rees M., van Trotsenburg M.Fuentes:scopus